BioNTech to invest $1.3B in the U.K. to boost R&D efforts

COVID vaccine maker BioNTech (NASDAQ:BNTX) has reached an agreement with the U.K. to invest £1B ($1.3B) in the country over the next 10 years to expand its research & development activities as part of a government-backed partnership.

The German biotech